Marshall Morningstar

Synthesis and Biological Activity of Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 2-Aryl-Substituted Benzimidazoles

Thomas Roth, Marshall Morningstar, Paul L. Boyer et al. · Journal of Medicinal Chemistry · 1997 · 369 citations · Full text

Antiviral Drug, Hiv-1 Wt Rt, Pharmaceutical Chemistry +16

Diversity-oriented synthesis yields novel multistage antimalarial inhibitors

Nobutaka Kato, Eamon Comer, Tomoyo Sakata‐Kato et al. · Nature · 2016 · 261 citations · Full text

Diversity-oriented Synthesis Yields, Medicinal Chemistry, Diversity Oriented Synthesis +7

X-ray structure of a DNA decamer containing 7,8-dihydro-8-oxoguanine.

Leigh Ann Lipscomb, Mary Elizabeth Peek, Marshall Morningstar et al. · Proceedings of the National Academy of Sciences · 1995 · 216 citations · Full text

Dna Decamer, Nucleic Acid Chemistry, Dna +15

Genetic effects of oxidative DNA damage: comparative mutagenesis of 7,8-dihydro-8-oxoguanine and 7,8-dihydro-8-oxoadenine in<i>Escherichia coli</i>

Michael L. Wood, Asunción Esteve, Marshall Morningstar et al. · Nucleic Acids Research · 1992 · 196 citations · Full text

Dna Damage, Genetics, Molecular Biology +19

Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II: Broad-Spectrum Antibacterial Agents with Reduced hERG Activity

Folkert Reck, Richard A. Alm, Patrick Brassil et al. · Journal of Medicinal Chemistry · 2011 · 101 citations · Full text

Reduced Herg Activity, Antimicrobial Chemotherapy, Pharmaceutical Chemistry +21